Greenwich LifeSciences, Inc. | Business Contracts

Open Market Sale Agreement, dated July 12, 2022 by and between the Company and Jefferies LLC (Filed With SEC on July 12, 2022)

Underwriting Agreement, dated December 17, 2020 (Filed With SEC on December 22, 2020)

Employment Agreement by and between Greenwich LifeSciences, Inc. and Snehal Patel dated September 29, 2020 (Filed With SEC on October 1, 2020)

Second Amendment to Exclusive License Agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the Company (Filed With SEC on June 23, 2020)

Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2021)

Form of Underwriting Agreement (Filed With SEC on December 15, 2020)

Underwriting Agreement, dated September 24, 2020 (Filed With SEC on September 28, 2020)

Form of Underwriting Agreement (Filed With SEC on September 9, 2020)

Registration Rights Agreement (Filed With SEC on June 23, 2020)

Form of Employment Agreement between the Company and Snehal Patel, to be effective on the closing of the offering contemplated by this registration statement (Filed With SEC on June 23, 2020)

American Arbitration Association Award of Arbitrators (Filed With SEC on June 23, 2020)

First Amendment to Exclusive License Agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the Company (Filed With SEC on June 23, 2020)

Exclusive License Agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the Company (Filed With SEC on June 23, 2020)

Form of Underwriter Warrant (Filed With SEC on June 23, 2020)

Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on June 23, 2020)

Form of Underwriting Agreement (Filed With SEC on June 23, 2020)

Form of Indemnification Agreement with directors and executive officers (Filed With SEC on May 29, 2020)

2019 Equity Incentive Plan (Filed With SEC on May 29, 2020)

Greenwich LifeSciences, Inc. (18)